A comprehensive dive into the contract research organization field offers a glimpse into how the virus has affected firms, and what the future might hold.
A leader from the contract research organization explains how home health personnel, decentralized trial technology and other services can help avoid study interruptions
A leader with the industry association discusses the surging interest in harnessing artificial intelligence to advance various treatments and therapies.
The agency continues to offer advice related to drug development and clinical research during the pandemic, and take action against those falling out of line.
A leader from the clinical development services firm recommends clinical trials change their tack to avoid costly clinical trial interruptions in the face of the pandemic.
The clinical trial company launched the trial around cytokine storm, an immunological reaction associated with severe virus cases, in 15 business days.
A leader with the patient recruitment specialist talks about the need for clinical trials to balance their important work with what’s important to participants.
The federal agency continues to monitor as the virus impacts the pharma and clinical trials industries, offering advice and taking action where necessary.
